OakChart

Summit Therapeutics Inc

SMMTHealthcare·Biotechnology·USA·Large·NASD·Nov 11 • 3:21 PM ET

16.80-1.03 (-5.78%)
2026-11-11 21:22 CET
Market cap
14,223.88 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-832.68 USD m
Free cash flow, TTM
-523.70 USD m
EPS diluted, TTM
-1.07
P/E
-
Compare

Price

SMMT against its 20, 50 and 200-day averages
2050200beatmiss
12.5015.0017.5020.0013.7M27.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SMMTclose 16.8020-day 15.8150-day 16.47200-day 16.1616.8052w low

42.5% under the 52-week high of 29.23 on 21 Apr 2026. 52-week low 12.07 on 17 Aug 2026. Last 15 sessions, 28.1% high to low

Volume 0.50× normal · the line is the 50-bar volume average

Profile

SMMT
52-week range, 28% of the way up
12.0729.23

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

IndexRUI
Employees265
IPOMar 05, 2015
Beta-1.52
ATR, 14d1.21
Rel volume0.50
Short float27.76%
Insider own80.92%
Inst own17.00%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap13.40B
Enterprise Value12.79B
Income-832.68M
Sales0.00M
Book/sh0.71
Cash/sh0.79
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees265
IPOMar 05, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B23.79
P/C21.27
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio5.99
Current Ratio5.99
Debt/Eq0.04
LT Debt/Eq0.03
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.07
EPS next Y-1.01
EPS next Q-0.30
EPS this Y26.90%
EPS next Y3.87%
EPS next 5Y23.48%
EPS past 3/5Y-52.45% -13.76%
Sales past 3/5Y- -
EPS Y/Y TTM13.96%
Sales Y/Y TTM-
EPS Q/Q16.26%
Sales Q/Q-
EarningsNov 04 AMC
EPS/Sales Surpr.7.70% -100.00%

Ownership

Insider Own80.92%
Insider Trans1.23%
Inst Own17.00%
Inst Trans10.15%
ROA-174.46%
ROE-220.01%
ROIC-143.36%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA206.30%
SMA502.03%
SMA2003.97%
Trades-

Technical

Shs Outstand799.73M
Shs Float152.24M
Short Float27.76%
Short Ratio6.75
Short Interest42.26M
52W High29.23 -42.52%
52W Low12.07 39.19%
Volatility10.21% 7.00%
ATR (14)1.21
RSI (14)53.27
Beta-1.52
Rel Volume0.50
Avg Volume6.26M
Volume2,860,836

Performance

Perf Week3.90%
Perf Month8.25%
Perf Quarter20.00%
Perf Half Y-10.59%
Perf YTD-3.95%
Perf Year-12.32%
Perf 3Y781.89%
Perf 5Y218.18%
Perf 10Y52.59%
Recom1.59
Target Price29.99
Prev Close17.83
Price16.80
Change %-5.78%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 09, 2026UpgradeJJefferiesHold → Buy$25+48.8%
Aug 25, 2026UpgradeBBernsteinUnderperform → Mkt Perform$11.90-29.2%
Aug 12, 2026UpgradeLLeerink PartnersUnderperform → Market Perform$13-22.6%
May 22, 2026DowngradeHH.C. WainwrightBuy → Neutral
Apr 08, 2026InitiatedSStifelBuy$45+167.9%
Mar 16, 2026DowngradeJJefferiesBuy → Hold$15-10.7%
Dec 17, 2025UpgradeBBarclaysUnderweight → Equal Weight$18+7.1%
Nov 18, 2025InitiatedWWolfe ResearchPeer Perform
Sep 17, 2025InitiatedBBarclaysUnderweight$13-22.6%
Sep 04, 2025InitiatedGGuggenheimBuy$40+138.1%

Peers

Mkt cap
TickerCompanyMkt cap
BNTXBioNTech SE ADR21.65B
CBIOCrescent Biopharma Inc538.95M
GMABGenmab ADR32.84B
ONCBeOne Medicines Ltd ADR44.23B
EXELExelixis Inc17.18B
MRKMerck & Co Inc361.80B
PFEPfizer Inc167.80B
IOVAIovance Biotherapeutics Inc3.70B
BMYBristol-Myers Squibb Co128.44B
CMPXCompass Therapeutics Inc148.66M

Insider trading

5 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Zanganeh MahkamCo-Chief Executive OfficerJun 12 '26Buy13.123,810,00049,987,200573,883,879Jun 12 02:35 PM
DUGGAN ROBERT WCo-Chief Executive OfficerJun 12 '26Buy13.123,810,00049,987,200573,883,879Jun 12 12:28 PM
DUGGAN ROBERT WCo-Chief Executive OfficerJun 04 '26Buy14.60100,0001,460,00025,824,474Jun 04 06:08 PM
Zanganeh MahkamCo-Chief Executive OfficerJun 04 '26Buy14.60100,0001,460,00025,824,474Jun 04 05:45 PM
Soni Manmeet SinghCOO and CFOJun 04 '26Buy14.4550,000722,2503,123,603Jun 04 04:40 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IBBiShares Biotechnology ETFAUM: 11.36B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B
PINKSimplify Health Care ETFAUM: 350.61M
IWRiShares Russell Mid-Cap ETFAUM: 58.68B
IWFiShares Russell 1000 Growth ETFAUM: 116.57B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-04-0.260-0.282-0.2600.000.1110
2026Q22026-07-23-0.280-0.274-0.2770.000.0014
2026Q12026-04-30-0.240-0.269-0.2440.000.0515
2025Q42026-02-23-0.290-0.077-0.2860.000.0014
2025Q32025-10-20-0.310-0.170-0.3120.000.0015
2025Q22025-08-11-0.760-0.091-0.7620.000.0011
2025Q12025-05-01-0.090-0.093-0.0850.000.009
2024Q42025-02-24-0.080-0.082-0.0830.000.007
2024Q32024-10-30-0.050-0.067-0.0770.000.003
2024Q22024-08-06-0.050-0.062-0.0850.000.002
2024Q12024-05-01-0.060-0.060-0.0620.000.001
2023Q42024-02-20-0.050--0.0520.00--
2023Q32023-11-07---0.031---
2023Q22023-08-09---0.021---
2023Q12023-05-11-1.430--1.4340.01--
2022Q42023-03-09-0.070--0.0910.01--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.164-0.342-0.18719.8619.43
2020FY-0.760-0.800-0.7580.86-
2021FY-0.960--0.9611.81-
2022FY-0.410--0.4080.71-
2023FY-0.992--0.9920.00-
2024FY-0.310-0.296-0.3080.000.00
2025FY-1.440-1.114-1.4400.000.00
2026FY--1.053--2.50
2027FY--1.012--59.23
2028FY--0.645--580.4
2029FY-0.139--1,748
2030FY-1.553--3,948

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0911113.010.0010.80
2026Q4S2026-11-0510113.310.0010.80
2026Q4S2026-11-049004.290.0015.00
2026Q4S2026-11-019004.290.0015.00
2026Q4S2026-10-2813004.270.0015.00
2026Q4S2026-10-0714003.970.0015.00
2026Q4S2026-10-0214103.970.0015.00
2026Q4S2026-09-1614113.970.0015.00
2026Q4S2026-08-1214123.970.0015.00
2026Q4S2026-07-2413114.270.0015.00
2026Q4S2026-07-1512003.460.0014.00
2026Q4S2026-06-2012023.460.0014.00
2026Q4S2026-06-0413024.220.0014.00
2026Q4S2026-05-2614024.060.0014.00

Estimate history

EPS, annual-0.4010.579-0.187-0.758-0.961-0.408-0.992-0.308-1.444-1.0685
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.077-0.083-0.085-0.762-0.312-0.286-0.244-0.277-0.261
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual16.06657.0150.8110.861.8090.7050000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual73.56432.078335.8982.57598.04211.091701.66737.626775.371799.726
Period201720182019202020212022202320242025MRQ
Shares, quarterly737.095737.626741.609742.807744.443775.371776.017793.12799.726
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.701.810.860.8157.01
Cost of Goods Sold Incl. D&A0.220.150.092.052.51----
Gross Profit-0.22-0.15-0.09-2.05-1.81----
Selling, General and Administrative Excl. Other855.031,094.28211.2287.6977.49106.5170.5053.9266.37
Research and Development606.77537.67150.7859.4752.3584.3452.0241.9950.83
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-855.24-1,094.42-211.30-89.74-79.30-107.15-71.65-54.90-10.87
Interest Expense0.000.008.6916.464.400.280.260.040.00
Unusual Expense0.000.0015.01520.927.200.000.380.001.88
Net Income Before Taxes-832.68-1,079.59-221.63-615.87-83.31-103.81-62.27-36.476.23
Income Taxes0.000.00-0.31-0.95-4.52-15.21-9.58-5.81-3.75
Consolidated Net Income-832.68-1,079.59-221.32-614.93-78.78-88.60-52.70-30.669.98
Net Income From Continuing Operations-832.68-1,079.59-221.32-614.93-78.78-88.60-52.70-30.669.98
Net Income-832.68-1,079.59-221.32-614.93-78.78-88.60-52.70-30.669.98
EPS (Recurring)-1.04-1.44-0.29-0.40-0.38-0.96-0.75-0.190.66
EPS (Basic, Before Extraordinaries)-1.07-1.44-0.31-0.99-0.41-0.96-0.76-0.190.58
EPS (Diluted)-1.07-1.44-0.31-0.99-0.41-0.96-0.76-0.190.58
EBITDA-855.03-1,094.28-211.22-87.69-76.79-104.70-69.64-53.11-9.36
Non-Operating Income (Expense)22.5614.8413.3711.247.603.6310.0118.4718.97
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense300.96732.4250.9814.1111.9510.371.430.735.09
Price To Earnings Ratio--------11.05
Price To Sales Ratio----1,165.50137.16379.96323.690.40
Gross Margin-----256.60----
Operating Margin-----11,248.51-5,923.38-8,330.93-6,766.38-19.06
Net Margin-----11,174.75-4,897.84-6,127.56-3,779.0717.50
Shares Outstanding799.73775.37737.63701.66211.0998.0482.58335.8932.08
Market Capitalization14,223.8814,223.8813,153.461,821.39855.61262.62386.62107.4842.65

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.090.050.040.040.040.040.030.02
Gross Profit-0.09-0.05-0.04-0.04-0.04-0.04-0.03-0.02
Selling, General and Administrative Excl. Other214.53220.45195.17224.88234.17568.4066.8365.78
Research and Development169.13157.73132.62147.29131.10208.0251.2751.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-214.61-220.50-195.21-224.93-234.21-568.44-66.85-65.80
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-208.39-215.70-189.42-219.17-231.79-565.71-62.91-61.40
Income Taxes0.000.000.000.000.000.000.00-0.20
Consolidated Net Income-208.39-215.70-189.42-219.17-231.79-565.71-62.91-61.20
Net Income From Continuing Operations-208.39-215.70-189.42-219.17-231.79-565.71-62.91-61.20
Net Income-208.39-215.70-189.42-219.17-231.79-565.71-62.91-61.20
EPS (Recurring)-0.26-0.28-0.24-0.29-0.31-0.76-0.09-0.08
EPS (Basic, Before Extraordinaries)-0.26-0.28-0.24-0.29-0.31-0.76-0.09-0.08
EPS (Diluted)-0.26-0.28-0.24-0.29-0.31-0.76-0.09-0.08
EBITDA-214.53-220.45-195.17-224.88-234.17-568.40-66.83-65.78
Non-Operating Income (Expense)6.234.805.795.752.422.733.944.40
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense47.6968.7172.79111.78130.76478.7811.1011.00
Shares Outstanding799.73793.12776.02775.37744.44742.81741.61737.63
Market Capitalization14,223.8811,308.6914,114.6412,989.2315,343.4815,803.9314,228.8113,153.46

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments713.76412.67186.24648.6171.7966.4264.1435.3328.59
Short Term Receivables0.000.560.856.1217.1610.196.8016.3713.21
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets6.5410.522.621.998.3611.078.809.789.24
Total Current Assets720.30423.75189.71656.7197.3187.6779.7461.4751.04
Net Property, Plant & Equipment21.687.406.065.083.481.281.550.811.15
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets2.001.861.891.8012.4113.5515.5816.3424.55
Other Assets7.212.555.280.580.170.000.000.000.00
Total Assets751.18435.56202.95664.17113.37102.5096.8778.6276.74
Short Term Debt Incl. Current Port. of LT Debt3.393.772.8121.461.090.390.470.000.00
Accounts Payable20.294.642.670.364.376.144.495.826.28
Other Current Liabilities49.3133.3314.9316.9720.1613.367.7511.1126.10
Total Current Liabilities72.9941.7320.4138.7825.6219.8912.7116.9332.37
Long Term Debt17.503.45103.29497.301.690.080.420.000.00
Provision for Risks Charges0.000.000.000.000.000.002.722.432.33
Deferred Tax Liabilities------2.072.203.38
Other Liabilities1.831.631.561.432.783.080.501.0943.17
Total Liabilities92.3246.81125.26537.5130.0923.0518.4122.6681.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity658.86388.7577.69126.6583.2879.4578.4655.96-4.53
Total Shareholders Equity658.86388.7577.69126.6583.2879.4578.4655.96-4.53
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity658.86388.7577.69126.6583.2879.4578.4655.96-4.53
Total Liabilities & Stockholders Equity751.18435.56202.95664.17113.37102.5096.8778.6276.74
Book Value Per Share0.850.530.110.600.850.960.231.74-0.06
Tangible Book Value Per Share0.850.520.110.590.720.800.191.24-0.40
Full-Time Employees2651591057711081706176
Price to Book Ratio25.2530.0418.336.423.174.886.223.8171.93
Return on Assets-181.94-69.32-141.83-20.26-82.09-52.86-12.84-42.32
Return on Equity-206.10-94.90-601.85-75.05-108.89-66.74-28.51-192.14
Return on Invested Capital-159.62-56.43-339.77-12.63-104.27-66.26-38.8717.83-
Quick Ratio9.8710.159.3016.933.804.416.273.631.58
Current Ratio9.8710.159.3016.933.804.416.273.631.58

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-819.37-1,079.59-221.32-614.93-78.78-88.60-52.70-32.606.67
Depreciation0.220.150.092.052.512.462.001.641.51
Other Funds (Non Cash)277.34725.0963.64538.4926.0713.631.969.768.04
Funds from Operations-541.81-354.35-157.59-74.39-50.20-72.52-48.73-21.2116.21
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital19.8231.4215.48-2.378.62-0.070.621.23-51.73
Cash from Operating Activities-521.99-322.93-142.11-76.76-41.58-72.59-48.11-19.98-35.51
Capital Expenditures-1.71-0.66-0.14-0.13-0.62-0.31-0.42-0.34-0.17
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.230.000.000.000.00-
Purchase or Sale of Investments-474.78-173.65-190.20-112.860.000.000.000.000.00
Purchase of Investments-1,141.26-484.99-680.03-321.020.000.000.000.000.00
Sale Or Maturity of Investments666.49311.34489.84208.170.000.000.000.000.00
Other Uses0.000.00-15.01-475.020.000.000.000.00-0.25
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-476.48-174.31-205.34-587.77-0.62-0.31-0.42-0.34-0.42
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock908.39617.53481.23111.20100.2977.9750.5548.5544.32
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock908.39617.53481.23111.20100.2977.9750.5548.5544.32
Proceedsfrom Stock Options388.16104.5343.03104.0799.8974.8849.9548.5544.19
Issuance or Reduction of Debt, Net0.000.00-100.00-24.69519.960.000.000.000.00
Change in Long Term Debt0.000.00-100.00-24.69519.960.000.000.000.00
Issuance of Long Term Debt0.000.000.000.00544.960.000.000.000.00
Reduction of Long Term Debt0.000.00-100.00-24.69-25.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities908.39617.53381.2386.51620.2477.9250.5548.1044.32
Exchange Rate Effect-0.050.10-0.020.84-1.220.350.56-0.270.57
Net Change in Cash-90.14120.4033.76-577.18576.825.372.5827.508.96
Free Cash Flow-523.70-323.59-142.25-76.89-42.21-72.89-48.53-20.19-35.67
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments630.10691.00599.05713.76238.88298.19
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets30.6329.5817.556.547.5911.05
Total Current Assets660.73720.58616.60720.30246.47309.24
Net Property, Plant & Equipment21.1921.1921.0621.686.236.24
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.981.971.972.002.002.04
Other Assets8.968.458.237.217.036.52
Total Assets692.85752.19647.86751.18261.73324.04
Short Term Debt Incl. Current Port. of LT Debt3.853.553.183.392.723.12
Accounts Payable32.7222.9027.5520.2922.2522.98
Other Current Liabilities73.6677.1252.5449.3139.9634.23
Total Current Liabilities110.23103.5783.2772.9964.9360.33
Long Term Debt16.1316.8316.8617.502.712.44
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.811.801.801.831.831.84
Total Liabilities128.17122.20101.9292.3269.4764.60
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity564.68629.98545.93658.86192.26259.44
Total Shareholders Equity564.68629.98545.93658.86192.26259.44
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity564.68629.98545.93658.86192.26259.44
Total Liabilities & Stockholders Equity692.85752.19647.86751.18261.73324.04
Book Value Per Share0.710.790.700.850.260.35
Tangible Book Value Per Share0.700.790.700.850.260.35
Full-Time Employees---265--
Price to Book Ratio25.2520.7122.3167.7259.1545.83
Return on Assets-174.46-159.09-233.81-181.94-241.08-224.08
Return on Equity-220.01-192.50-270.95-206.10-292.49-328.30
Return on Invested Capital-35.88-33.35-33.66-32.40-118.89-216.02
Quick Ratio5.996.967.419.873.805.13
Current Ratio5.996.967.419.873.805.13

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-208.87-214.82-189.42-206.25-235.97-584.28
Depreciation0.090.050.040.040.040.04
Other Funds (Non Cash)43.9465.4868.7699.16132.76491.86
Funds from Operations-164.85-149.30-120.62-107.05-103.17-92.38
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital4.738.75-1.688.018.0221.85
Cash from Operating Activities-160.12-140.55-122.29-99.03-95.14-70.52
Capital Expenditures-0.40-0.91-0.25-0.16-0.07-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-203.30223.320.01-494.81-0.97160.01
Purchase of Investments-250.45-224.12-177.29-489.410.000.00
Sale Or Maturity of Investments47.15447.44177.29-5.40-0.97160.01
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-203.69222.41-0.24-494.96-1.04159.99
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock95.73230.573.80578.2934.682.51
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock95.73230.573.80578.2934.682.51
Proceedsfrom Stock Options93.12226.920.0068.1234.702.66
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities95.73230.573.80578.2934.682.51
Exchange Rate Effect-0.010.00-0.02-0.020.020.06
Net Change in Cash-268.09312.43-118.75-15.73-61.4892.05
Free Cash Flow-160.51-141.46-122.54-99.19-95.22-70.54

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3027.76%42.3M152.2M6.03M
2026-10-1526.86%40.9M152.2M5.96M
2026-09-3027.02%41.2M152.3M5.57M
2026-09-1526.97%41.1M152.3M5.12M
2026-08-3127.13%41.3M152.3M5.49M
2026-08-1424.57%37.4M152.3M5.16M
2026-07-3126.97%36.2M134.4M5.26M
2026-07-1528.55%37.3M130.8M5.49M
2026-06-3030.48%39.9M130.8M5.29M
2026-06-1528.15%36.8M130.8M4.73M
2026-05-2926.87%36.1M134.5M3.69M
2026-05-1522.18%29.8M134.5M3.31M
2026-04-3021.80%29.2M133.9M2.96M
2026-04-1525.77%34.5M133.9M2.55M
2026-03-3133.56%34.6M103.0M2.71M
2026-03-1335.07%36.1M103.0M2.56M
2026-02-2733.67%34.7M103.0M2.61M
2026-02-1336.77%37.9M103.0M2.68M
2026-01-3035.90%37.0M103.0M2.66M
2026-01-1536.12%37.2M103.0M2.91M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.0011.3012.3012.5214.6226.000.000.968-0.2720.001
call6.0010.4011.3011.4712.1198.000.000.962-0.2650.001
call7.009.4010.4010.1011.5676.001.000.955-0.2660.001
call8.008.509.308.929.1538.001.000.948-0.2550.001
call9.007.508.207.857.5476.008.000.940-0.2540.001
call9.506.807.807.407.71357.003.000.935-0.2490.002
call10.006.407.406.877.47425354.000.930-0.2460.002
call10.505.906.906.427.08525244.000.924-0.2400.002
call11.004.906.405.566.5726.005.000.918-0.2350.002
call11.504.506.005.156.4455.002.000.911-0.2290.002
call12.003.805.504.645.9506.002.000.903-0.2230.002
call12.503.205.004.225.3661.002.000.895-0.2170.002
call13.003.305.404.376.4100.001.000.884-0.2090.002
call13.502.904.903.927.0120.001.000.871-0.1990.003
call14.002.454.604.706.89124.002.000.857-0.1910.003
call14.502.154.502.207.08212.000.000.842-0.1780.003
call15.001.804.102.986.99742.000.000.784-0.2070.004
call15.501.353.101.805.27418.001.000.693-0.3020.004
call16.001.151.451.742.13265511.000.651-0.2650.004
call16.500.951.451.252.7453046.000.573-0.3360.005
call17.000.851.100.812.4392194.000.511-0.3050.005
call17.500.701.000.802.72122871.000.468-0.3940.005
call18.000.350.850.672.75433891.000.423-0.3950.005
call18.500.400.650.462.6443304.000.340-0.3120.004
call19.000.300.600.452.82417549.000.306-0.3190.004
call19.500.200.700.603.09885.001.000.288-0.3400.004
call20.000.150.350.252.68825743.000.209-0.2490.003
call20.500.002.300.302.86616.000.000.198-0.2530.003
call21.000.150.250.202.81421436.000.155-0.2150.003
call21.500.002.250.003.0050.000.000.147-0.2220.003
call22.000.050.200.232.9851000.000.123-0.1950.002
call22.500.002.200.003.1530.000.000.118-0.2000.002
call23.000.000.250.103.2001082.000.114-0.1950.002
call23.500.000.200.083.46752.0012.000.110-0.2100.002
call24.000.052.150.053.6284.001.000.106-0.2140.002
call24.500.002.150.003.1740.000.000.065-0.1280.002
call25.000.000.200.103.40333.0040.000.084-0.1650.002
call25.500.002.150.003.4290.000.000.061-0.1320.001
call26.000.000.100.113.78316.000.000.079-0.1730.002
call26.500.002.150.003.7300.000.000.058-0.1380.001
call27.000.002.150.003.7850.000.000.056-0.1370.001
call27.500.002.150.003.9100.000.000.055-0.1380.001
call28.000.002.150.004.0080.000.000.054-0.1400.001
call28.500.002.150.004.1150.000.000.053-0.1420.001
call29.000.002.150.004.2660.000.000.052-0.1450.001
call29.500.002.150.004.3800.000.000.051-0.1470.001
call30.000.002.150.004.4170.000.000.050-0.1440.001
call30.500.002.150.004.5140.000.000.049-0.1470.001
call31.000.002.150.004.6080.000.000.048-0.1470.001
call32.000.002.150.154.86456.000.000.047-0.1530.001
put5.000.002.150.0011.7700.000.00-0.032-0.2680.001
put6.000.002.150.0010.0780.000.00-0.038-0.2630.001
put7.000.002.150.008.8000.000.00-0.045-0.2650.001
put8.000.001.200.007.6490.000.00-0.052-0.2600.001
put9.000.001.200.006.5040.000.00-0.059-0.2430.001
put9.500.001.000.006.1400.000.00-0.065-0.2490.002
put10.000.002.150.155.6384.000.00-0.069-0.2390.002
put10.500.001.000.005.2560.000.00-0.075-0.2400.002
put11.000.002.150.224.80228.000.00-0.081-0.2300.002
put11.500.002.150.254.4084.000.00-0.088-0.2240.002
put12.000.002.000.224.0361110.00-0.097-0.2210.002
put12.500.000.350.063.6621130.00-0.106-0.2140.002
put13.000.000.350.053.2985370.00-0.116-0.2060.002
put13.500.000.700.382.9411050.00-0.129-0.1980.003
put14.000.050.250.102.615390259-0.143-0.1890.003
put14.500.100.250.152.24328843.00-0.163-0.1760.003
put15.000.200.350.252.21047241.00-0.214-0.2060.004
put15.500.150.550.402.43340.001.00-0.311-0.3140.004
put16.000.500.700.602.20112227.00-0.363-0.2860.005
put16.500.551.100.802.62449.0067.00-0.424-0.3350.005
put17.000.801.201.152.28041.0011.00-0.493-0.3060.005
put17.500.802.351.404.01513.002.00-0.533-0.3920.005
put18.000.053.301.275.3368.000.00-0.576-0.3850.005
put18.500.253.603.605.32711.000.00-0.660-0.3100.004
put19.001.954.004.515.3961.000.00-0.695-0.3180.004
put19.501.104.500.005.7060.000.00-0.714-0.3390.004
put20.001.504.700.005.3530.000.00-0.792-0.2470.003
put20.501.955.200.005.6840.000.00-0.802-0.2580.003
put21.002.405.700.005.9170.000.00-0.844-0.2070.003
put21.502.906.000.005.6790.000.00-0.853-0.2200.003
put22.004.506.700.005.2050.000.00-0.877-0.1930.002
put22.504.006.200.004.0820.000.00-0.882-0.1980.002
put23.004.306.700.004.3690.000.00-0.886-0.2030.002
put23.504.807.900.006.3080.000.00-0.890-0.2070.002
put24.005.308.500.006.7510.000.00-0.933-0.1230.002
put24.505.808.800.005.9680.000.00-0.935-0.1250.002
put25.006.308.600.004.5990.000.00-0.900-0.2180.002
put25.506.8010.000.007.3640.000.00-0.902-0.2220.002
put26.007.3010.300.006.9630.000.00-0.941-0.1330.001
put26.507.8010.800.007.1260.000.00-0.943-0.1350.001
put27.008.3011.209.667.0661.000.00-0.944-0.1370.001
put27.508.8011.309.796.0083.000.00-0.945-0.1380.001
put28.0010.5011.6011.275.4366.006.00-0.946-0.1400.001
put28.509.9012.1011.705.7036.007.00-0.947-0.1410.001
put29.0010.3012.8011.306.4107.001.00-0.948-0.1420.001
put29.5011.1013.2012.126.4216.004.00-0.949-0.1420.001
put30.0011.3014.6012.558.9134.004.00-0.950-0.1450.001
put30.5011.8015.0012.948.7973.004.00-0.951-0.1460.001
put31.0012.3015.4013.278.6674.002.00-0.952-0.1470.001
put32.0013.3015.8014.487.2521.000.00-0.953-0.1490.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-04424B7SEC
2026-10-19DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-04SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-10-06PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-06SEC
2026-09-298-KCurrent report2026-09-28SEC
2026-09-158-KCurrent report2026-09-15SEC
2026-09-148-KCurrent report2026-09-13SEC
2026-09-038-KCurrent report2026-09-02SEC
2026-08-268-KCurrent report2026-08-25SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-2310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-238-KCurrent report2026-07-23SEC
2026-07-238-KCurrent report2026-07-23SEC
2026-07-23424B5SEC
2026-07-228-KCurrent report2026-07-22SEC
2026-06-128-KCurrent report2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-118-KCurrent report2026-06-10SEC
2026-06-10424B5SEC
2026-06-09S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-038-KCurrent report2026-06-02SEC
2026-06-018-KCurrent report2026-05-30SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-06103.62M500
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BAKER BROS. ADVISORS LP4.22%
STATE STREET CORP1.23%
BlackRock, Inc.1.23%
FMR LLC1.02%
VANGUARD CAPITAL MANAGEMENT LLC0.74%
VANGUARD PORTFOLIO MANAGEMENT LLC0.65%
GOLDMAN SACHS GROUP INC0.58%
PRICE T ROWE ASSOCIATES INC /MD/0.50%
Point72 Asset Management, L.P.0.48%
GEODE CAPITAL MANAGEMENT, LLC0.44%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF0.96%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.48%
VANGUARD SMALL-CAP INDEX FUND0.34%
T. Rowe Price Health Sciences Fund, Inc.0.33%
Fidelity Growth Company Fund0.26%
VANGUARD EXTENDED MARKET INDEX FUND0.23%
VANGUARD SMALL-CAP VALUE INDEX FUND0.22%
abrdn Healthcare Investors0.14%
Select Biotechnology Portfolio0.13%
iShares Biotechnology ETF0.12%

OakChart. SMMT. Cached 15 minutes.